docetaxel anhydrous has been researched along with Hospital-Acquired Condition in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Awazawa, R; Hirata, T; Miyagi, T; Ohira, A; Takahashi, K; Yamashiro, A; Zamami, R | 1 |
1 other study(ies) available for docetaxel anhydrous and Hospital-Acquired Condition
| Article | Year |
|---|---|
Successful treatment of iatrogenic Kaposi's sarcoma with low-dose docetaxel therapy.
Topics: Aged; Antineoplastic Agents; Docetaxel; Humans; Iatrogenic Disease; Immunosuppressive Agents; Japan; Male; Sarcoma, Kaposi; Skin Neoplasms; Taxoids | 2018 |